Randomized Trialhigh evidence
Ticagrelor with aspirin dual antiplatelet therapy combined with intravenous thrombolysis in patients with ischaemic stroke in China (TAPIS): a multicentre, double-blind, randomised controlled trial.
Lancet (London, England)·May 16, 2026·PMID 42114550
Why it mattersThis trial provides high-quality evidence that early DAPT after thrombolysis for moderate stroke improves functional recovery without a clear safety signal, addressing a key clinical uncertainty in acute stroke management.
The papers that matter, first.
MedLit ranks the medical literature into a specialty feed with concise summaries, evidence-aware triage, and visual takeaways.
§
MedLit · Evidence, Distilled